Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21494548 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment
Condition: Tuberculosis
Interventions: Drug: Moxifloxacin (with rifampin, pyrazinamide, and ethambutol);   Drug: isoniazid

Indicates status has not been verified in more than two years